JoVE Logo

Meld u aan

3.5 : Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an orally administered drug can be determined by comparing its plasma concentration with that of the same drug administered intravenously. A graph can be plotted that shows the plasma concentration of a drug over time, given in equivalent doses both orally and intravenously. The total area under this graph for each method of administration signifies the degree of drug absorption via that particular route. By calculating the ratio of these areas, an estimate of the bioavailable fraction of an orally administered drug can be obtained.

Tags

BioavailabilitySystemic CirculationDrug AdministrationGastrointestinal AbsorptionLiver BiotransformationIntravenous AdministrationPlasma ConcentrationDrug AbsorptionAdministration RoutesBioavailable Fraction

Van hoofdstuk 3:

article

Now Playing

3.5 : Bioavailability: Overview

Pharmacokinetics

2.6K weergaven

article

3.1 : Pharmacokinetics: Overview

Pharmacokinetics

5.3K weergaven

article

3.2 : Drug Absorption Mechanism: Passive Membrane Transport

Pharmacokinetics

3.4K weergaven

article

3.3 : Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Pharmacokinetics

3.3K weergaven

article

3.4 : Drug Absorption: Factors Affecting GI Absorption

Pharmacokinetics

3.6K weergaven

article

3.6 : Factors Influencing Bioavailability: First-Pass Elimination

Pharmacokinetics

5.9K weergaven

article

3.7 : Bioequivalence: Overview

Pharmacokinetics

892 weergaven

article

3.8 : First Pass Effect

Pharmacokinetics

4.9K weergaven

article

3.9 : Time Course of Drug Effect

Pharmacokinetics

1.8K weergaven

article

3.10 : Drug Distribution: Tissue Binding

Pharmacokinetics

2.4K weergaven

article

3.11 : Physiological Barriers

Pharmacokinetics

3.3K weergaven

article

3.12 : Drug Distribution: Plasma Protein Binding

Pharmacokinetics

4.5K weergaven

article

3.13 : Compartment Models: Single-Compartment Model

Pharmacokinetics

2.1K weergaven

article

3.14 : Compartment Models: Two-Compartment Model

Pharmacokinetics

5.0K weergaven

article

3.15 : Drug Distribution: Volume of Distribution

Pharmacokinetics

4.2K weergaven

See More

JoVE Logo

Privacy

Gebruiksvoorwaarden

Beleid

Onderzoek

Onderwijs

Over JoVE

Auteursrecht © 2025 MyJoVE Corporation. Alle rechten voorbehouden